Cornelis J.A. Punt
Impact in
- Oncology top 0.02%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 233
- Colorectal Cancer Treatments and Studies 140
- Colorectal Cancer Surgical Treatments 23
- Cancer Treatment and Pharmacology 23
-
- Gastric Cancer Management and Outcomes 31
- Co-authors
- Miriam Koopman (117 shared papers)I. Jolanda M. de Vries (44 shared papers)Carl G. Figdor (41 shared papers)W. Joost Lesterhuis (26 shared papers)Gosse J. Adema (31 shared papers)J. Han van Krieken (19 shared papers)Irıs D. Nagtegaal (34 shared papers)Jolien Tol (14 shared papers)
- Journals
- Journal of Clinical Oncology (55 papers)Annals of Oncology (38 papers)European Journal of Cancer (37 papers)British Journal of Cancer (17 papers)Cancer Research (12 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Cornelis J.A. Punt
386 papers receiving 24.8k citations
Cornelis J.A. Punt's Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 14.2k
- Hepatology 2.0k
- Immunology 5.4k
- Cancer Research 3.1k
- Pathology and Forensic Medicine 2.5k
Countries citing papers authored by Cornelis J.A. Punt
This map shows the geographic impact of Cornelis J.A. Punt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelis J.A. Punt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelis J.A. Punt more than expected).
Fields of papers citing papers by Cornelis J.A. Punt
This network shows the impact of papers produced by Cornelis J.A. Punt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelis J.A. Punt. The network helps show where Cornelis J.A. Punt may publish in the future.
Co-authors
The 25 scholars most cited alongside Cornelis J.A. Punt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 396 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 1531 |
| 2 | Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer Hit paper breakdown → | 2009 | 1039 |
| 3 | Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Hit paper breakdown → | 1998 | 1020 |
| 4 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2010 | 779 |
| 5 | Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy Hit paper breakdown → | 2005 | 704 |
| 6 | Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies Hit paper breakdown → | 2014 | 556 |
| 7 | Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study Hit paper breakdown → | 2022 | 533 |
| 8 | 2007 | 474 | |
| 9 | Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database Hit paper breakdown → | 2016 | 455 |
| 10 | From tumour heterogeneity to advances in precision treatment of colorectal cancer Hit paper breakdown → | 2016 | 453 |
| 11 | 2008 | 451 | |
| 12 | 2009 | 438 | |
| 13 | Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial Hit paper breakdown → | 2017 | 429 |
| 14 | Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. | 2003 | 422 |
| 15 | 2009 | 379 | |
| 16 | 2011 | 345 | |
| 17 | 2015 | 306 | |
| 18 | 2013 | 301 | |
| 19 | 2012 | 299 | |
| 20 | 2011 | 287 |
About Cornelis J.A. Punt
Cornelis J.A. Punt is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Pathology and Forensic Medicine and Cancer Research, having authored 396 papers that have together received 25.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (140 papers), Immunotherapy and Immune Responses (47 papers), Genetic factors in colorectal cancer (46 papers), Hepatocellular Carcinoma Treatment and Prognosis (36 papers), Cancer Genomics and Diagnostics (33 papers), Gastric Cancer Management and Outcomes (31 papers), Colorectal Cancer Surgical Treatments (23 papers) and Cancer Treatment and Pharmacology (23 papers). The work is most often cited by research in Oncology (14.2k citations), Hepatology (2.0k citations), Immunology (5.4k citations), Cancer Research (3.1k citations) and Pathology and Forensic Medicine (2.5k citations). Cornelis J.A. Punt has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Miriam Koopman, I. Jolanda M. de Vries, Carl G. Figdor, W. Joost Lesterhuis, Gosse J. Adema, J. Han van Krieken, Irıs D. Nagtegaal, Jolien Tol, Linda Mol and Leon W.M.M. Terstappen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.